nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in structure-based drug design
|
Schaffhausen, Joanna |
|
2012 |
33 |
5 |
p. 223- 1 p. |
artikel |
2 |
Discovery of boceprevir, a direct-acting NS3/4A protease inhibitor for treatment of chronic hepatitis C infections
|
Venkatraman, Srikanth |
|
2012 |
33 |
5 |
p. 289-294 6 p. |
artikel |
3 |
Editorial Board
|
|
|
2012 |
33 |
5 |
p. i- 1 p. |
artikel |
4 |
Experiences in fragment-based drug discovery
|
Murray, Christopher W. |
|
2012 |
33 |
5 |
p. 224-232 9 p. |
artikel |
5 |
Iminoheterocycle as a druggable motif: BACE1 inhibitors and beyond
|
Zhu, Zhaoning |
|
2012 |
33 |
5 |
p. 233-240 8 p. |
artikel |
6 |
New insights from structural biology into the druggability of G protein-coupled receptors
|
Mason, Jonathan S. |
|
2012 |
33 |
5 |
p. 249-260 12 p. |
artikel |
7 |
Rapid-access, high-throughput synchrotron crystallography for drug discovery
|
Wasserman, Stephen R. |
|
2012 |
33 |
5 |
p. 261-267 7 p. |
artikel |
8 |
Structural approaches to obtain kinase selectivity
|
Norman, Richard A. |
|
2012 |
33 |
5 |
p. 273-278 6 p. |
artikel |
9 |
Structural biology and drug discovery for protein–protein interactions
|
Jubb, Harry |
|
2012 |
33 |
5 |
p. 241-248 8 p. |
artikel |
10 |
Structure-based drug screening for G-protein-coupled receptors
|
Shoichet, Brian K. |
|
2012 |
33 |
5 |
p. 268-272 5 p. |
artikel |
11 |
The role of structural information in the discovery of direct thrombin and factor Xa inhibitors
|
Nar, Herbert |
|
2012 |
33 |
5 |
p. 279-288 10 p. |
artikel |